Results 1 to 10 of about 30,792 (197)
The Varied Sensitivity of Partial Thromboplastin and Prothrombin Time Reagents in the Demonstration of the Lupus‐Like Anticoagulant [PDF]
Scandinavian Journal of Haematology, 1979 An acquired inhibitor of blood coagulation, similar to that described in patients with Systemic Lupus Erythematosus (SLE), was detected during routine coagulation screening in 10 patients who did not meet the criteria for a diagnosis of SLE.
P.M. Mannucci +3 more
openalex +2 more sources
The Thromboplastin Generation Test [PDF]
Journal of Clinical Pathology, 1953 A. S. Douglas, Rosemary Biggs
openaire +4 more sources
A Novel Thromboplastin-Based Rat Model of Ischemic Stroke
Brain Sciences, 2021 The thromboembolic ischemia model is one of the most applicable for studying ischemic stroke in humans. The aim of this study was to develop a novel thromboembolic stroke model, allowing, by affordable tools, to reproduce cerebral infarction in rats.
Irina V. Ostrova +3 more
doaj +1 more source
The role of hemostatic changes in the pathogenesis of diabetic retinopathy
Journal of Education, Health and Sport, 2022 Introduction: The paper presents the results of the hemostasis system of rats with experimental diabetic retinopathy. Material and methods: Experimental studies were performed on white Wistar rats, which were divided into 2 groups: 1st group – intact
Nataliya Preys, Ivan Savytskyi
doaj +1 more source
Thromboplastin Bilbao: Reproducibility and Sensitivity of a Spanish Thromboplastin [PDF]
Pathophysiology of Haemostasis and Thrombosis, 2002 Prothrombin time (PT) is the control test for oral anticoagulant therapy as well as the screening test for defects of the extrinsic pathway of coagulation. Its responsiveness to decreased extrinsic clotting factors depends on the source and type of tissue factor thromboplastin extract. In 1994, a rabbit brain thromboplastin – Thromboplastin Bilbao (TBi)
I. Unanue +4 more
openaire +3 more sources
Frontiers in Neurology, 2020 Background: Lupus anticoagulant (LA) owns procoagulant properties in vivo and prolongs phospholipid-dependent clotting times in vitro. The prolonged in vitro clotting time can be misinterpreted as a bleeding disorder.
Aydin Huseynov +10 more
doaj +1 more source
UMYU Journal of Microbiology Research, 2021 Coronavirus disease 2019 (COVID-19) is associated with coagulation abnormalities- disordered hemostasis and high thrombotic risk. The aim of the study was to compare and analyze the clotting profiles between COVID-19 and non-COVID-19 patients in Barau ...
Abdulfatai K +5 more
doaj +1 more source
Frontiers in Oncology, 2017 Tissue factor (TF)-expressing tumor-derived extracellular vesicles (EVs) can promote metastasis and pre-metastatic niche formation, but the mechanisms by which this occurs remain largely unknown. We hypothesized that generation of activated factor X (FXa)
Sara P. Y. Che +2 more
doaj +1 more source
Implications of deranged activated partial thromboplastin time for anaesthesia and surgery
Anaesthesia, 2018 Bleeding during and after surgery ranges from trivial to fatal. Bleeding is in part determined by the patient's coagulation status. The UK National Institute for Health and Care Excellence recommends a pre‐operative clotting test for patients with a ...
E. Loizou +3 more
semanticscholar +1 more source